Publications by authors named "F Roesch"

Claim this Profile
E
Efficacy and Safety of [Lu]Lu-DOTAGA.Glu.(FAPi) Therapy in Patients with Sarcoma.
Sanjana Ballal, Mohammad Sakir, Kunal R Chandekar, Sameer Rastogi, Madhav P Yadav, Frank Roesch

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways.
Sejal Chopra, Jaya Shukla, Priyavrat Purohit, Umanath Adhikari, Frank Roesch

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison Between [ 68 Ga]Ga-DOTA.SA.FAPi And [ 18 F]F-FDG PET/CT Imaging in Patients With Sarcoma.
Mohammad Sakir, Sanjana Ballal, Sameer Rastogi, Madhav Prasad Yadav, Frank Roesch

Clin Nucl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68 Ga-DATA 5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients.
Sanjana Ballal, Parvind Sheokand, Madhav P Yadav, Frank Roesch, Rahul Viswanathan

Clin Nucl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [Lu]Lu-DOTAGA.FAPi Dimer Therapy.
Sanjana Ballal, Madhav Prasad Yadav, Swayamjeet Satapathy, Frank Roesch, Kunal R Chandekar

Thyroid· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis